ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 56 filers reported holding ENZON PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $340,000 | -28.3% | 723,072 | +4.2% | 0.00% | – |
Q4 2015 | $474,000 | -34.3% | 694,026 | -6.6% | 0.00% | -100.0% |
Q3 2015 | $721,000 | -15.2% | 743,207 | +5.0% | 0.00% | 0.0% |
Q2 2015 | $850,000 | +13.0% | 707,921 | -0.2% | 0.00% | 0.0% |
Q1 2015 | $752,000 | -2.5% | 709,021 | +0.2% | 0.00% | 0.0% |
Q4 2014 | $771,000 | – | 707,951 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ancora Advisors LLC | 50,000 | $20,000 | 0.00% |
MONARCH CAPITAL MANAGEMENT INC/ | 10,000 | $4,000 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 122,287 | $50,000 | 0.00% |
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 254,200 | $103,000 | 0.00% |
TUDOR INVESTMENT CORP ET AL | 47,998 | $19,000 | 0.00% |
O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 11,181 | $5,000 | 0.00% |
Kistler-Tiffany Companies, LLC | 825 | $0 | 0.00% |
Tradewinds Capital Management, LLC | 200 | $0 | 0.00% |
NEXT Financial Group, Inc | 60 | $0 | 0.00% |
CT Financial Advisors LLC | 2,000 | $810,000 | 0.00% |